Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Evaluation and treatment of iron deficiency in patients with kidney disease.

Bickford AK.

Nutr Clin Care. 2002 Sep-Oct;5(5):225-30. Review.

PMID:
12455224
2.

Evaluating iron status in hemodialysis patients.

Enders HM.

Nephrol Nurs J. 2002 Aug;29(4):366-70. Review.

PMID:
12224370
3.

Considerations for optimal iron use for anemia due to chronic kidney disease.

Hudson JQ, Comstock TJ.

Clin Ther. 2001 Oct;23(10):1637-71. Review.

PMID:
11726002
4.

Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.

Tarng DC, Huang TP, Chen TW, Yang WC.

Kidney Int Suppl. 1999 Mar;69:S107-18. Review.

PMID:
10084294
5.

Assessing iron status: beyond serum ferritin and transferrin saturation.

Wish JB.

Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S4-8. Review.

6.

Iron status and iron supplementation in peritoneal dialysis patients.

Vychytil A, Haag-Weber M.

Kidney Int Suppl. 1999 Mar;69:S71-8. Review.

PMID:
10084290
7.

Diagnosing and treating anemia and iron deficiency in hemodialysis patients.

Foret JP.

Nephrol Nurs J. 2002 Jun;29(3):292-6. Review.

PMID:
12164080
8.

Hypochromic red blood cells and reticulocytes.

Schaefer RM, Schaefer L.

Kidney Int Suppl. 1999 Mar;69:S44-8. Review.

PMID:
10084285
9.

Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?

Dukkipati R, Kalantar-Zadeh K.

Nephrol News Issues. 2007 Jan;21(1):34-8. Review.

PMID:
17269263
10.

Iron management in end-stage renal disease.

Fishbane S, Maesaka JK.

Am J Kidney Dis. 1997 Mar;29(3):319-33. Review.

PMID:
9041207
11.

Caring for the renal failure patient: optimizing iron therapy.

Folkert VW, Javier AM, O'Mara NB.

Nephrol Nurs J. 2002 Dec;29(6):586-93; quiz 594-5. Review.

PMID:
12596608
12.

Beneficial effects of iron therapy in renal failure patients on hemodialysis.

Fishbane S, Mittal SK, Maesaka JK.

Kidney Int Suppl. 1999 Mar;69:S67-70. Review.

PMID:
10084289
13.

Erythropoietin and iron.

Sunder-Plassmann G, Hörl WH.

Clin Nephrol. 1997 Mar;47(3):141-57. Review.

PMID:
9105761
14.

Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.

Fishbane S.

Semin Dial. 2008 May-Jun;21(3):217-20. doi: 10.1111/j.1525-139X.2007.00420.x. Epub 2008 Feb 1. Review.

PMID:
18248518
15.

Iron deficiency in patients with renal failure.

Nissenson AR, Strobos J.

Kidney Int Suppl. 1999 Mar;69:S18-21. Review.

PMID:
10084282
16.

Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.

Besarab A, Dalton CL.

Nephrol Nurs J. 2001 Aug;28(4):429-34. Review.

PMID:
12143465
17.

Intravenous iron for the treatment of predialysis anemia.

Silverberg DS, Blum M, Agbaria Z, Schwartz D, Zubkov A, Yachnin T, Iaina A.

Kidney Int Suppl. 1999 Mar;69:S79-85. Review.

PMID:
10084291
18.

Strategies for iron supplementation: oral versus intravenous.

Macdougall IC.

Kidney Int Suppl. 1999 Mar;69:S61-6. Review.

PMID:
10084288
19.

Evaluating traditional iron measures and exploring new options for patients on hemodialysis.

Petroff S.

Nephrol Nurs J. 2005 Jan-Feb;32(1):65-73; quiz 74-5. Review.

PMID:
15787086
20.

Iron monitoring and supplementation: how do we achieve the best results?

Schaefer RM, Schaefer L.

Nephrol Dial Transplant. 1998;13 Suppl 2:9-12. Review.

PMID:
9566484

Supplemental Content

Support Center